Back to Authors

Evans, Jonathan M.

Mayo Clinic

Mayo Clinic

Citations 3

Aortic Aneurysm and Dissection in Giant Cell Arteritis
Evans, Jonathan M., O'Fallon, W. Michael, Hunder, Gene G., O'Fallon, W. Michael, Hunder, Gene G.

Annals of Internal Medicine | April 12, 2013 | Volume: 124 | Issue: 6 | Pages: 615

10.7326/0003-4819-124-6-199603150-00023 Get It

Increased Incidence of Aortic Aneurysm and Dissection in Giant Cell (Temporal) Arteritis: A Population-Based Study
Evans, Jonathan M., O'Fallon, W. Michael, Hunder, Gene G., O'Fallon, W. Michael, Hunder, Gene G.

Annals of Internal Medicine | April 12, 2013 | Volume: 122 | Issue: 7 | Pages: 502-507

10.7326/0003-4819-122-7-199504010-00004 Get It

Congestive Heart Failure in the Community
Senni, Michele , Tribouilloy, Christophe M, Rodeheffer, Richard J. , Jacobsen, Steven J. , Evans, Jonathan M., Bailey, Kent R. , Redfield, Margaret M. , Senni, Michele

Circulation | June 11, 2012 | Volume: 98 | Issue: 21 | Pages: 2282-2289

10.1161/01.cir.98.21.2282 Get It

Background —Data are limited regarding the classification and prognosis of patients with congestive heart failure (CHF) in the community. Methods and Results —Using the resources of the Rochester Epidemiology Project, we evaluated all patients receiving a first diagnosis of CHF in Olmsted County, Minnesota, in 1991 (n=216). Among these patients, 88% were ≥65 years and 49% were ≥80 years of age. The prognosis of patients with a new diagnosis of CHF was poor; survival was 86±2% at 3 months, 76±3% at 1 year, and 35±3% at 5 years. Of the 216 patients, 137 (63%) had an assessment of ejection fraction. In these patients, systolic function was preserved (ejection fraction ≥50%) in 59 (43%) and reduced (ejection fraction <50%) in 78 (57%). Survival adjusted for age, sex, NYHA class, and coronary artery disease was not significantly different between patients with preserved and those with reduced systolic function (relative risk, 0.80; P =0.369). ACE inhibitors were used in only 44% of the total population with CHF. Conclusions —The present study reports the clinical characteristics and natural history of CHF as it presents in the community in the vasodilator era. CHF is a disease of the “very elderly,” frequently occurs in the setting of normal ejection fraction, and has a poor prognosis, regardless of the level of systolic function. Diagnostic and therapeutic methods are underused in the community.